Por que o preço das ações de QUEST DIAGNOSTICS INCORPORATED está subindo?
Os otimistas dizem
Consumer testing growth
Analyst highlights robust growth in consumer testing and direct-to-consumer channels that drives higher revenue per requisition through expanded high-value test panels.
Advanced diagnostics expansion
Expansion of advanced diagnostic testing is increasing tests per request and should remain durable given demographic trends and a rising chronic disease burden, supporting sustained volume growth.
Platform integration and access
Progress on the Haystack platform and planned electronic medical record integration, along with potential Medicare Advantage coverage, can boost clinician access and drive incremental testing volumes.
Reimbursement policy risk
Reimbursement changes under government payment programs create pressure on revenue and margins, posing a meaningful headwind to profitability.
Near-term margin weakness
Operating margin was pressured by project-related expenses and partner disruptions, signaling near-term profitability headwinds despite top-line strength.
Valuation sensitivity
Stock trades at a premium versus closest peers, increasing downside sensitivity if revenue or profitability momentum slows.
